Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0400
0.00 (0.00%)
Jul 20, 2026, 12:35 PM EST
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $17.9 million as of July 21, 2026. Its market cap has decreased by -13.54% in one year.
Market Cap
17.90M
Enterprise Value
31.08M
Revenue
n/a
Ranking
n/a
PE Ratio
0.07
Stock Price
$0.04
ChartMarket Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 17.90M, an increase of 95.82%. That is a compound annual growth rate of 9.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 17.90M | -51.78% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 26.93M |
| BetterLife Pharma | 26.06M |
| Provectus Biopharmaceuticals | 25.41M |
| EOM Pharmaceuticals Holdings | 18.98M |
| ZIVO Bioscience | 17.19M |
| Finch Therapeutics Group | 17.10M |
| Zeo ScientifiX | 14.26M |
| Inhibitor Therapeutics | 13.48M |